MR molecular imaging of aortic angiogenesis

JACC: Cardiovascular Imaging

Volumn 3, Issue 8, 2010, Pages 824-832

  Cai, Kejia ^a   Caruthers, Shelton D ^a   Huang, Wenjing ^a   Williams, Todd A ^a   Zhang, Huiying ^a   Wickline, Samuel A ^a   Lanza, Gregory M ^a   Winter, Patrick M ^a  

^a WASHINGTON UNIVERSITY   (United States)

Author keywords

James C. Russell:LA corpulent rat strain; JCR:LA cp; magnetic resonance; MR

Indexed keywords

BENFLUOREX; CHOLESTEROL; GLUCOSE; INSULIN; LEPTIN; NANOPARTICLE; TRIACYLGLYCEROL;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA; ARTICLE; ATHEROSCLEROSIS; BODY WEIGHT; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DECREASED APPETITE; DISEASE COURSE; DRUG EFFECT; FOOD INTAKE; HISTOLOGY; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OBESITY; PRIORITY JOURNAL; RAT; TRIACYLGLYCEROL BLOOD LEVEL;

ANIMALS; AORTA; APPETITE DEPRESSANTS; ATHEROSCLEROSIS; BODY WEIGHT; CHOLESTEROL; DISEASE MODELS, ANIMAL; EATING; FENFLURAMINE; INSULIN; INTEGRIN ALPHAVBETA3; LEPTIN; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; METABOLIC SYNDROME X; NANOPARTICLES; NEOVASCULARIZATION, PATHOLOGIC; OBESITY; RATS; TIME FACTORS; TRIGLYCERIDES;

EID: 77956635307     PISSN: 1936878X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcmg.2010.03.012     Document Type: Article

References (35)

1. W. Koenig, M. Sund, and M. Frohlich C-reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men: results from the MONICA (Monitoring Trends and Determinants in Cardiovascular Disease) Augsburg Cohort Study, 1984 to 1992 Circulation 99 1999 237 242
2. P.M. Ridker, J.E. Buring, N.R. Cook, and N. Rifai C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: an 8-year follow-up of 14 719 initially healthy American women Circulation 107 2003 391 397
3. P.M. Ridker, N. Rifai, L. Rose, J.E. Buring, and N.R. Cook Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events N Engl J Med 347 2002 1557 1565
4. O.J. de Boer, A.C. van der Wal, P. Teeling, and A.E. Becker Leucocyte recruitment in rupture prone regions of lipid-rich plaques: a prominent role for neovascularization? Cardiovasc Res 41 1999 443 449
5. F.D. Kolodgie, R. Virmani, and A.P. Burke Pathologic assessment of the vulnerable human coronary plaque Heart 90 2004 1385 1391
6. P.R. Moreno, K.R. Purushothaman, and V. Fuster Plaque neovascularization is increased in ruptured atherosclerotic lesions of human aorta: implications for plaque vulnerability Circulation 110 2004 2032 2038
7. R. Virmani, A.P. Burke, F.D. Kolodgie, and A. Farb Pathology of the thin-cap fibroatheroma: a type of vulnerable plaque J Interv Cardiol 16 2003 267 272
8. R. Virmani, F.D. Kolodgie, and A.P. Burke Atherosclerotic plaque progression and vulnerability to rupture: angiogenesis as a source of intraplaque hemorrhage Arterioscler Thromb Vasc Biol 25 2005 2054 2061
9. A.H. Schmieder, P.M. Winter, and S.D. Caruthers Molecular MR imaging of melanoma angiogenesis with alphanubeta3-targeted paramagnetic nanoparticles Magn Reson Med 53 2005 621 627
10. P.M. Winter, S.D. Caruthers, and A. Kassner Molecular imaging of angiogenesis in nascent Vx-2 rabbit tumors using a novel alpha(nu)beta3-targeted nanoparticle and 1.5 tesla magnetic resonance imaging Cancer Res 63 2003 5838 5843
11. P.M. Winter, S.D. Caruthers, and X. Yu Improved molecular imaging contrast agent for detection of human thrombus Magn Reson Med 50 2003 411 416
12. P.M. Winter, A.H. Schmieder, and S.D. Caruthers Minute dosages of alpha(nu)beta3-targeted fumagillin nanoparticles impair Vx-2 tumor angiogenesis and development in rabbits FASEB J 22 2008 2758 2767
13. J.C. Russell, S.E. Graham, and P.J. Dolphin Glucose tolerance and insulin resistance in the JCR:LA-corpulent rat: effect of miglitol (Bay m1099) Metabolism 48 1999 701 706
14. J.C. Russell, S.E. Graham, and M. Richardson Cardiovascular disease in the JCR:LA-cp rat Mol Cell Biochem 188 1998 113 126
15. J.C. Russell, D.G. Koeslag, R.M. Amy, and P.J. Dolphin Plasma lipid secretion and clearance in hyperlipidemic JCR:LA-corpulent rats Arteriosclerosis 9 1989 869 876
16. J.C. Russell, D.G. Koeslag, R.M. Amy, and P.J. Dolphin Independence of myocardial disease in the JCR:LA-corpulent rat on plasma cholesterol concentration Clin Invest Med 14 1991 288 295
17. D.N. Brindley, P. Hales, A.I. al-Sieni, and J.C. Russell Decreased serum lipids, serum insulin and triacylglycerol synthesis in adipose tissue of JCR:LA-corpulent rats treated with benfluorex Biochim Biophys Acta 1085 1991 119 125
18. J.C. Russell, S.E. Graham, P.J. Dolphin, R.M. Amy, G.O. Wood, and D.N. Brindley Antiatherogenic effects of long-term benfluorex treatment in male insulin resistant JCR:LA-cp rats Atherosclerosis 132 1997 187 197
19. J.C. Russell, S.E. Graham, P.J. Dolphin, and D.N. Brindley Effects of benfluorex on serum triacylglycerols and insulin sensitivity in the corpulent rat Can J Physiol Pharmacol 74 1996 879 886
20. D.F. Meoli, M.M. Sadeghi, and S. Krassilnikova Noninvasive imaging of myocardial angiogenesis following experimental myocardial infarction J Clin Invest 113 2004 1684 1691
21. M.M. Sadeghi, S. Krassilnikova, and J. Zhang Detection of injury-induced vascular remodeling by targeting activated alphavbeta3 integrin in vivo Circulation 110 2004 84 90
22. A.M. Neubauer, H. Sim, and P.M. Winter Nanoparticle pharmacokinetic profiling in vivo using magnetic resonance imaging Magn Reson Med 60 2008 1353 1361
23. P.R. Moreno, K.R. Purushothaman, M. Sirol, A.P. Levy, and V. Fuster Neovascularization in human atherosclerosis Circulation 113 2006 2245 2252
24. F.D. Kolodgie, H.K. Gold, and A.P. Burke Intraplaque hemorrhage and progression of coronary atheroma N Engl J Med 349 2003 2316 2325
25. F.D. Kolodgie, J. Narula, C. Yuan, A.P. Burke, A.V. Finn, and R. Virmani Elimination of neoangiogenesis for plaque stabilization: is there a role for local drug therapy? J Am Coll Cardiol 49 2007 2093 2101
26. D.A. Cheresh Integrins in thrombosis, wound healing and cancer Biochem Soc Trans 19 1991 835 838
27. M. Friedlander, C.L. Theesfeld, and M. Sugita Involvement of integrins alpha v beta 3 and alpha v beta 5 in ocular neovascular diseases Proc Natl Acad Sci U S A 93 1996 9764 9769
28. M.O. De Nichilo, and G.F. Burns Granulocyte-macrophage and macrophage colony-stimulating factors differentially regulate alpha v integrin expression on cultured human macrophages Proc Natl Acad Sci U S A 90 1993 2517 2521
29. O. Helluin, C. Chan, G. Vilaire, S. Mousa, W.F. DeGrado, and J.S. Bennett The activation state of alphavbeta 3 regulates platelet and lymphocyte adhesion to intact and thrombin-cleaved osteopontin J Biol Chem 275 2000 18337 18343
30. H. Itoh, P.R. Nelson, L. Mureebe, A. Horowitz, and K.C. Kent The role of integrins in saphenous vein vascular smooth muscle cell migration J Vasc Surg 25 1997 1061 1069 (Pubitemid 27265777)
31. P.M. Winter, A.M. Morawski, and S.D. Caruthers Molecular imaging of angiogenesis in early-stage atherosclerosis with alpha(v)beta3-integrin-targeted nanoparticles Circulation 108 2003 2270 2274
32. P.M. Winter, S.D. Caruthers, H. Zhang, T.A. Williams, S.A. Wickline, and G.M. Lanza Antiangiogenic synergism of integrin-targeted fumagillin nanoparticles and atorvastatin in atherosclerosis J Am Coll Cardiol Img 1 2008 624 634
33. P.M. Winter, A.M. Neubauer, and S.D. Caruthers Endothelial alpha(v)beta3 integrin-targeted fumagillin nanoparticles inhibit angiogenesis in atherosclerosis Arterioscler Thromb Vasc Biol 26 2006 2103 2109
34. J.C. Russell, P.J. Dolphin, S.E. Graham, R.M. Amy, and D.N. Brindley Improvement of insulin sensitivity and cardiovascular outcomes in the JCR:LA-cp rat by D-fenfluramine Diabetologia 41 1998 380 389
35. J.C. Russell, S.D. Proctor, S.E. Kelly, and D.N. Brindley Pair feeding-mediated changes in metabolism: stress response and pathophysiology in insulin-resistant, atherosclerosis-prone JCR:LA-cp rats Am J Physiol Endocrinol Metab 294 2008 E1078 E1087